Expert view: Delivering better therapeutics: fully characterising and recovering T cells

However, the functional heterogeneity of T cells can prove challenging during their development into therapeutics. These therapies have been associated with side effects relating to cytokine release syndrome (CRS) and neurotoxicity, placing extra importance on the understanding of functions such as cytokine release and killing kinetics at the single-cell level.